These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 35794852)

  • 21. Relationship between pre-existing allergies and anaphylactic reactions post mRNA COVID-19 vaccine administration.
    Desai AP; Desai AP; Loomis GJ
    Vaccine; 2021 Jul; 39(32):4407-4409. PubMed ID: 34215453
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reporting of Allergic Reactions During Pfizer-BioNTech BNTT162B2 Vaccination in Israel.
    Anis E; Preis SA; Cedar N; Tal Y; Hershkowitz I; Hershko AY
    J Allergy Clin Immunol Pract; 2022 Nov; 10(11):2969-2976. PubMed ID: 35872216
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risk stratification through allergy history: single-centre experience of specialized COVID-19 vaccine clinic.
    Lyons D; Murray C; Hannigan S; Sui J; Alamin S; Conlon N; Keogan M; Khalib K; Fitzpatrick C; O'B Hourihane J; Carey M; Edgar JDM
    Clin Exp Immunol; 2022 Aug; 209(2):182-187. PubMed ID: 35753019
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Allergic Reactions Including Anaphylaxis After Receipt of the First Dose of Moderna COVID-19 Vaccine - United States, December 21, 2020-January 10, 2021.
    ;
    MMWR Morb Mortal Wkly Rep; 2021 Jan; 70(4):125-129. PubMed ID: 33507892
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Rapid Development and Early Success of Covid 19 Vaccines Have Raised Hopes for Accelerating the Cancer Treatment Mechanism.
    Amanpour S
    Arch Razi Inst; 2021 Mar; 76(1):1-6. PubMed ID: 33818952
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Anaphylaxis caused by vaccines].
    Perea-Valle P; Delgado-Aguirre CJ; Villafuerte-Domínguez BG; Del Río-Navarro BE
    Rev Alerg Mex; 2022; 69 Suppl 1():s1-s14. PubMed ID: 34998305
    [TBL] [Abstract][Full Text] [Related]  

  • 27. First Month of COVID-19 Vaccine Safety Monitoring - United States, December 14, 2020-January 13, 2021.
    Gee J; Marquez P; Su J; Calvert GM; Liu R; Myers T; Nair N; Martin S; Clark T; Markowitz L; Lindsey N; Zhang B; Licata C; Jazwa A; Sotir M; Shimabukuro T
    MMWR Morb Mortal Wkly Rep; 2021 Feb; 70(8):283-288. PubMed ID: 33630816
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative Effectiveness of Moderna, Pfizer-BioNTech, and Janssen (Johnson & Johnson) Vaccines in Preventing COVID-19 Hospitalizations Among Adults Without Immunocompromising Conditions - United States, March-August 2021.
    Self WH; Tenforde MW; Rhoads JP; Gaglani M; Ginde AA; Douin DJ; Olson SM; Talbot HK; Casey JD; Mohr NM; Zepeski A; McNeal T; Ghamande S; Gibbs KW; Files DC; Hager DN; Shehu A; Prekker ME; Erickson HL; Gong MN; Mohamed A; Henning DJ; Steingrub JS; Peltan ID; Brown SM; Martin ET; Monto AS; Khan A; Hough CL; Busse LW; Ten Lohuis CC; Duggal A; Wilson JG; Gordon AJ; Qadir N; Chang SY; Mallow C; Rivas C; Babcock HM; Kwon JH; Exline MC; Halasa N; Chappell JD; Lauring AS; Grijalva CG; Rice TW; Jones ID; Stubblefield WB; Baughman A; Womack KN; Lindsell CJ; Hart KW; Zhu Y; Mills L; Lester SN; Stumpf MM; Naioti EA; Kobayashi M; Verani JR; Thornburg NJ; Patel MM;
    MMWR Morb Mortal Wkly Rep; 2021 Sep; 70(38):1337-1343. PubMed ID: 34555004
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Thyroid Inconveniences With Vaccination Against SARS-CoV-2: The Size of the Matter. A Systematic Review.
    Caironi V; Pitoia F; Trimboli P
    Front Endocrinol (Lausanne); 2022; 13():900964. PubMed ID: 35813627
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Safety Monitoring of COVID-19 Vaccine Booster Doses Among Adults - United States, September 22, 2021-February 6, 2022.
    Hause AM; Baggs J; Marquez P; Myers TR; Su JR; Blanc PG; Gwira Baumblatt JA; Woo EJ; Gee J; Shimabukuro TT; Shay DK
    MMWR Morb Mortal Wkly Rep; 2022 Feb; 71(7):249-254. PubMed ID: 35176008
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Double-Blind, Randomized, Placebo-Controlled Phase III Clinical Trial to Evaluate the Efficacy and Safety of treating Healthcare Professionals with the Adsorbed COVID-19 (Inactivated) Vaccine Manufactured by Sinovac - PROFISCOV: A structured summary of a study protocol for a randomised controlled trial.
    Palacios R; Patiño EG; de Oliveira Piorelli R; Conde MTRP; Batista AP; Zeng G; Xin Q; Kallas EG; Flores J; Ockenhouse CF; Gast C
    Trials; 2020 Oct; 21(1):853. PubMed ID: 33059771
    [TBL] [Abstract][Full Text] [Related]  

  • 32. New Onset and Exacerbations of Psoriasis Following COVID-19 Vaccines: A Systematic Review.
    Wu PC; Huang IH; Wang CW; Tsai CC; Chung WH; Chen CB
    Am J Clin Dermatol; 2022 Nov; 23(6):775-799. PubMed ID: 36048409
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Allergic Reactions After the Administration of COVID-19 Vaccines.
    Bian S; Li L; Wang Z; Cui L; Xu Y; Guan K; Zhao B
    Front Public Health; 2022; 10():878081. PubMed ID: 35655467
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevalence of Allergic Reactions After Pfizer-BioNTech COVID-19 Vaccination Among Adults With High Allergy Risk.
    Shavit R; Maoz-Segal R; Iancovici-Kidon M; Offengenden I; Haj Yahia S; Machnes Maayan D; Lifshitz-Tunitsky Y; Niznik S; Frizinsky S; Deutch M; Elbaz E; Genaim H; Rahav G; Levy I; Belkin A; Regev-Yochay G; Afek A; Agmon-Levin N
    JAMA Netw Open; 2021 Aug; 4(8):e2122255. PubMed ID: 34463744
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cutaneous and hypersensitivity reactions associated with COVID-19 vaccination-a narrative review.
    Wollina U; Chiriac A; Kocic H; Koch A; Brzezinski P
    Wien Med Wochenschr; 2022 Mar; 172(3-4):63-69. PubMed ID: 34424434
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Side effects after COVID-19 vaccinations among residents of Poland.
    Andrzejczak-Grządko S; Czudy Z; Donderska M
    Eur Rev Med Pharmacol Sci; 2021 Jun; 25(12):4418-4421. PubMed ID: 34227078
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Responding to COVID-19 vaccine-related safety events: WHO Western Pacific regional experience and lessons learned.
    Cho H; Amarasinghe A; Takashima Y
    Western Pac Surveill Response J; 2023; 14(2):1-6. PubMed ID: 37492237
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Effectiveness of Pfizer-BioNTech and Oxford-AstraZeneca Vaccines to Prevent Severe COVID-19 in Costa Rica: Nationwide, Ecological Study of Hospitalization Prevalence.
    Rosero-Bixby L
    JMIR Public Health Surveill; 2022 May; 8(5):e35054. PubMed ID: 35483079
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The safety profile of COVID-19 vaccinations in the United States.
    Singh A; Khillan R; Mishra Y; Khurana S
    Am J Infect Control; 2022 Jan; 50(1):15-19. PubMed ID: 34699960
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effectiveness of Pfizer-BioNTech and Moderna Vaccines in Preventing SARS-CoV-2 Infection Among Nursing Home Residents Before and During Widespread Circulation of the SARS-CoV-2 B.1.617.2 (Delta) Variant - National Healthcare Safety Network, March 1-August 1, 2021.
    Nanduri S; Pilishvili T; Derado G; Soe MM; Dollard P; Wu H; Li Q; Bagchi S; Dubendris H; Link-Gelles R; Jernigan JA; Budnitz D; Bell J; Benin A; Shang N; Edwards JR; Verani JR; Schrag SJ
    MMWR Morb Mortal Wkly Rep; 2021 Aug; 70(34):1163-1166. PubMed ID: 34437519
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.